Answers are grounded in this paper and cite their sources.
Following early observations of higher than expected mortality among intubated patients with severe COVID-19, many physicians expressed doubt that that the initial presentations were entirely consistent with “classic ARDS” [ 1 ]. Large observational studies suggest that, ultimately, hospitalized patients with persistent COVID-19 associated ARDS develop lung-mechanics similar to other sepsis-based ARDS and that COVID-19 associated ARDS pathology is highly similar to ARDS of any cause [ 2 , 3 , 4 ]. These patients accumulate inflammatory infiltrates in the lung parenchyma, oxidative stress from the high FiO 2 and mechanical microtrauma from positive pressure mechanical ventilation—all factors leading to diffuse alveolar damage, which is the most common histologic pattern identified in patients with ARDS [ 5 ]. Pathologic examination of patients with COVID-19 associated ARDS in Wuhan, China revealed alveolar epithelial injury, reactive hyperplasia of Type II pneumocytes, hyaline membrane formation, and fibroblastic plugs in the air-spaces, all indicative of how COVID-19 associated ARDS can rapidly devolve into a fatal state of minimal gas exchange [ 6 ]. Despite the ongoing investigations in COVID-19, the optimal management of acute respiratory distress syndrome (ARDS) morbidity remains ill-defined but increasingly critical and is in need of safe, new and effective therapeutic treatments.
No takes yet. Share an insight, caveat, or question.
Sengupta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: